Company Overview of Edge Therapeutics, Inc.
Edge Therapeutics, Inc., a hospital-focused biopharmaceutical company, designs and develops implantable technology for direct delivery of therapeutic compounds to the site of brain injury. Its drugs cover therapeutic areas, such as spontaneous brain hemorrhage, traumatic brain injuries, and brain surgeries. The company develops NimoGel and NimoVent to prevent delayed cerebral ischemia, a catastrophic delayed complication after subarachnoid hemorrhage. Its therapeutics are delivered to patients in the United States and internationally. The company was founded in 2009 and is based in Newark, New Jersey.
211 Warren Street
Newark, NJ 07103
Founded in 2009
Key Executives for Edge Therapeutics, Inc.
Edge Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Matrixx Initiatives, Inc.||United States|
|Javelin Pharmaceuticals, Inc.||United States|
|Synapsin Pharmaceuticals, Inc.||United States|
|Sierra Radiopharmacy LLC||United States|
|Kineta, Inc.||United States|
Recent Private Companies Transactions
March 18, 2013
August 31, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Stockton, CA | AstraZenecaPosted: May 20
- Princeton, NJ | RGPPosted: May 02
Sponsored Financial Commentaries
To contact Edge Therapeutics, Inc., please visit www.edgetherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.